Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,897,816
+$180,556 QoQ
Shares Held
14,769
+3.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#1,625
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HEADINVEST, LLC holds $15,409,722 across 8 Drug Manufacturers - General names. MRK ranks #5 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
88,590 | $4,247,004 | |
| 2 | NVS |
Novartis AG
|
15,391 | $2,412,077 | |
| 3 | ABBV |
AbbVie Inc.
|
9,300 | $2,340,252 | |
| 4 | LLY |
ELI LILLY & Co
|
1,634 | $1,959,868 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
14,769 | $1,897,816 | |
| 6 | JNJ |
Johnson & Johnson
|
7,126 | $1,809,790 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,791 | $391,297 | |
| 8 | AMGN |
Amgen Inc
|
971 | $351,618 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,897,816 | 14,769 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,717,260 | 14,276 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,683,949 | 15,998 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $1,085,718 | 12,936 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,077,209 | 13,608 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,375,661 | 15,326 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,125,091 | 21,362 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $2,481,853 | 21,855 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $2,756,407 | 22,265 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,045,010 | 23,077 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $2,780,773 | 25,507 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,682,671 | 26,058 | Shares | Sole | 2023-12-11 | |
| 2023-06-30 | $3,028,295 | 26,244 | Shares | Sole | 2023-08-23 | |
| 2023-03-31 | $2,935,512 | 27,592 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $3,000,420 | 27,043 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,361,152 | 27,417 | Shares | Sole | 2022-12-28 | |
| 2022-06-30 | $2,536,075 | 27,817 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,237,257 | 27,267 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,087,980 | 27,244 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,054,483 | 27,353 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $2,140,308 | 27,521 | Shares | Sole | 2021-08-30 | |
| 2021-03-31 | $2,107,487 | 27,338 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,178,905 | 26,637 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,769,158 | 21,328 | Shares | Sole | 2020-11-24 | |
| 2020-06-30 | $1,570,418 | 20,308 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,533,028 | 19,925 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||